Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Pander HJ"'
Autor:
Gallon R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. Electronic address: richard.gallon@newcastle.ac.uk., Phelps R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Hayes C; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Brugieres L; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Guerrini-Rousseau L; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Team 'Genomics and Oncogenesis of pediatric Brain Tumors,' INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Colas C; Département de Génétique, Institut Curie, Paris, France; INSERM U830, Université de Paris, Paris, France., Muleris M; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche Saint-Antoine, Paris, France., Ryan NAJ; The Academic Women's Health Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Department of Gynaecology Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK., Evans DG; Division of Evolution, Infection and Genomics, University of Manchester, Manchester, UK., Grice H; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Jessop E; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Kunzemann-Martinez A; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Centre for Inflammation and Tissue Repair, University College London, London, UK., Marshall L; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Schamschula E; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Oberhuber K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Azizi AA; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Baris Feldman H; The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Beilken A; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Brauer N; Pediatric Oncology, Helios-Klinikum, Krefeld, Germany., Brozou T; Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany., Dahan K; Centre de Génétique Humaine, Institut de Pathologie et Génétique, Gosselies, Belgium., Demirsoy U; Department of Pediatric Oncology, Kocaeli University, Kocaeli, Turkey., Florkin B; Department of Pediatrics, Citadelle Hospital, University of Liège, Liège, Belgium., Foulkes W; Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada; Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantation Medical University, Poznan, Poland., Jones KJ; Department of Clinical Genetics, Western Sydney Genetics Program, Children's Hospital at Westmead, Sydney, New South Wales, Australia; University of Sydney School of Medicine, Sydney, New South Wales, Australia., Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Lobitz S; Gemeinschaftsklinikum Mittelrhein, Department of Pediatric Hematology and Oncology, Koblenz, Germany., Meade J; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Nathrath M; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany; Department of Pediatrics, Pediatric Oncology Center, Technische Universität München, Munich, Germany., Pander HJ; Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany., Perne C; Institute of Human Genetics, Medical Faculty, University of Bonn and National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Ragab I; Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Rosenbaum T; Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany., Rueda D; Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain., Sarosiek T; Department of Oncology, Luxmed Onkologia, Warsaw, Poland., Sehested A; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Spier I; Institute of Human Genetics, Medical Faculty, University of Bonn and National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Suerink M; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Zimmermann SY; Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital, Frankfurt, Germany., Zschocke J; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Borthwick GM; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Burn J; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Jackson MS; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Santibanez-Koref M; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Publikováno v:
Gastroenterology [Gastroenterology] 2023 Apr; Vol. 164 (4), pp. 579-592.e8. Date of Electronic Publication: 2022 Dec 29.
Autor:
González-Acosta M; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Marín F; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Puliafito B; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Bonifaci N; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Fernández A; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Salvador H; Pediatric Oncology Unit, Hospital Sant Joan de Déu, Esplugues, Barcelona, Spain., Balaguer F; Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Iglesias S; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Velasco A; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Institut d'Investigació Biomèdica de Girona - IDIBGI, Girona, Spain., Grau Garces E; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Moreno V; Cancer Prevention and Control Program, Catalan Institute of Oncology - ICO, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain., Gonzalez-Granado LI; Immunodeficiencies Unit, Department of Pediatrics, Doce de Octubre University Hospital, i+12 Research Institute; Complutense University of Madrid, Madrid, Spain., Guerra-García P; Hematology and Oncology Unit, Department of Pediatrics, Doce de Octubre University Hospital, Madrid, Spain., Ayala R; Department of Hematology, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain., Florkin B; University Department of Pediatrics, CHR Citadelle, Liege, Belgium., Kratz C; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Rosenbaum T; Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany., Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantation, Poznań University of Medical Sciences, Poznań, Poland., Azizi AA; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Ragab I; Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Nathrath M; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany.; Pediatric Oncology Center, Department of Pediatrics, Technische Universität München, Munchen, Germany., Pander HJ; Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany., Lobitz S; Department of Pediatric Oncology/Pediatric Hematology, Kliniken der Stadt Köln gGmbH, Children's Hospital Amsterdamer Strasse, Koln, Germany., Suerink M; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Dahan K; Centre de Génétique Humaine, Institut de Pathologie et de Génétique (IPG), Gosselies, Belgium., Imschweiler T; Pediatric Oncology, Helios-Klinikum, Krefeld, Germany., Demirsoy U; Department of Pediatric Oncology, Kocaeli Universitesi, Kocaeli, Turkey., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Institut d'Investigació Biomèdica de Girona - IDIBGI, Girona, Spain., Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain., Rueda D; Hereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain., Wimmer K; Division of Human Genetics, Medical University Innsbruck, Innsbruck, Austria., Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain gcapella@iconcologia.net mpineda@iconcologia.net., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain gcapella@iconcologia.net mpineda@iconcologia.net.
Publikováno v:
Journal of medical genetics [J Med Genet] 2020 Apr; Vol. 57 (4), pp. 269-273. Date of Electronic Publication: 2019 Sep 07.
Autor:
Gallon R; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Mühlegger B; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Wenzel SS; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Sheth H; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Hayes C; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Aretz S; Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany., Dahan K; Centre de génétique humaine, Institut de pathologie et génétique (IPG), Gosselies, Belgium., Foulkes W; Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Azizi AA; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Baris Feldman H; The Genetics Institute, Rambam Health Care Campus, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Chong AL; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Demirsoy U; Department of Pediatric Oncology, Kocaeli University, Kocaeli, Turkey., Florkin B; Department of Pediatrics, CHR Citadelle Hospital, University of Liège, Liège, Belgium., Imschweiler T; Pediatric Oncology, Helios-Klinikum, Krefeld, Germany., Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantation, Poznań University of Medical Sciences, Poznań, Poland., Lobitz S; Department of Pediatric Oncology/Pediatric Hematology, Kliniken der Stadt Köln gGmbH, Children's Hospital Amsterdamer Strasse, Köln, Germany., Nathrath M; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany.; Department of Pediatrics, Pediatric Oncology Center , Technische Universität München, Munich, Germany., Pander HJ; Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany., Perez-Alonso V; Pediatrics Department, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain., Perne C; Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany., Ragab I; Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Rosenbaum T; Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany., Rueda D; Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain., Seidel MG; Research Unit Pediatric Hematology and Immunology, Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria., Suerink M; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands., Taeubner J; Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children´s Hospital, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany., Zimmermann SY; Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital, Frankfurt, Germany., Zschocke J; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Borthwick GM; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Burn J; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Jackson MS; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Santibanez-Koref M; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Wimmer K; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Publikováno v:
Human mutation [Hum Mutat] 2019 May; Vol. 40 (5), pp. 649-655. Date of Electronic Publication: 2019 Mar 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pander HJ; Institut für Klinische Genetik Olgahospital-Städtische Frauenklinik Obere Str. 2 70190 Stuttgart.
Publikováno v:
Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege [Kinderkrankenschwester] 2001 Mar; Vol. 20 (3), pp. 96-102.
Autor:
Dörk T; Institut für Humangenetik, Medizinische Hochschule Hannover, Germany., Dworniczak B, Aulehla-Scholz C, Wieczorek D, Böhm I, Mayerova A, Seydewitz HH, Nieschlag E, Meschede D, Horst J, Pander HJ, Sperling H, Ratjen F, Passarge E, Schmidtke J, Stuhrmann M
Publikováno v:
Human genetics [Hum Genet] 1997 Sep; Vol. 100 (3-4), pp. 365-77.
Autor:
de Kok YJ; Department of Human Genetics, University Hospital Nijmegen, The Netherlands., Vossenaar ER, Cremers CW, Dahl N, Laporte J, Hu LJ, Lacombe D, Fischel-Ghodsian N, Friedman RA, Parnes LS, Thorpe P, Bitner-Glindzicz M, Pander HJ, Heilbronner H, Graveline J, den Dunnen JT, Brunner HG, Ropers HH, Cremers FP
Publikováno v:
Human molecular genetics [Hum Mol Genet] 1996 Sep; Vol. 5 (9), pp. 1229-35.
Autor:
Pander HJ, Schwinger E
Publikováno v:
American journal of human genetics [Am J Hum Genet] 1995 May; Vol. 56 (5), pp. 1245-7.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Medizinische Genetik. Jun2021, Vol. 33 Issue 2, p189-195. 7p.